Complex treatment options of hip osteoarthritis

Cover Page


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Osteoarthritis has the highest prevalence among the musculoskeletal diseases in all economically developed countries. Despite the improvement of diagnostic and treatment methods, the number of patients with osteoarthritis is increasing. The number of cases of newly diagnosed osteoarthritis, cases of disease progression and subsequent disability are also growing. There are many guidelines for treatment of osteoarthritis, however, specialists have no consensus, especially regarding the amount and duration of conservative therapy.

The aim of the study was to analyze publications providing complex treatment options of hip osteoarthritis.

A systematic literature review has been conducted by means of the open acccess Pub-Med/MEDLINE database and eLibrary search for the period until January 2022. The search depth was 20 years and was performed by keywords and phrases: “hip joint osteoarthritis”, “conservative treatment”, “minimally invasive surgery”, “total hip arthroplasty”.

Unfortunately, the screening criteria for patients with osteoarthritis for total hip arthroplasty are not developed. The review analyzes the options of conservative therapy and minimally invasive surgical treatment for patients with osteoarthritis as the opportunity to avoid or delay the total hip replacement. The hip arthroplasty is not considered the “gold” standard; joint decision on surgery based on a comprehensive approach is made only when all the possibilities of conservative therapy are exhausted.

It is widely believed that complex treatment using modern conservative and organ-preserving methods is the most common strategy for managing osteoarthritis of the hip joint. This approach improves clinical and functional condition of patients and slows down the progression of the disease.

Full Text

Restricted Access

About the authors

Irina L. Urazovskaya

North-Western State Medical University named after I.I. Mechnikov

Email: langelova@yandex.ru
ORCID iD: 0000-0003-4165-4599
SPIN-code: 9263-4316
Scopus Author ID: 36544644000

MD, Cand. Sci. (Med.)

Russian Federation, 41 Kirochnaya St., Saint Petersburg, 191015

Sergey A. Saiganov

North-Western State Medical University named after I.I. Mechnikov

Email: sergey.sayganov@szgmu.ru
ORCID iD: 0000-0001-8325-1937
SPIN-code: 2174-6400

MD, Dr. Sci. (Med.), Professor

Russian Federation, 41 Kirochnaya St., Saint Petersburg, 191015

Vadim I. Mazurov

North-Western State Medical University named after I.I. Mechnikov

Email: vadim.mazurov@szgmu.ru
ORCID iD: 0000-0002-0797-2051
SPIN-code: 6823-5482
Scopus Author ID: 16936315400
ResearcherId: J-9643-2014

MD, Dr. Sci. (Med.), Professor, Academician of the RAS, Honoured Science Worker

Russian Federation, 41 Kirochnaya St., Saint Petersburg, 191015

Valerii M. Khaidarov

North-Western State Medical University named after I.I. Mechnikov

Email: drxaydarov@mail.ru
ORCID iD: 0000-0002-0754-4348
SPIN-code: 7083-3254

MD, Cand. Sci. (Med.)

Russian Federation, 41 Kirochnaya St., Saint Petersburg, 191015

Djalolidin S. Mansurov

Samarkand State Medical University

Email: jalolmedic511@gmail.com
ORCID iD: 0000-0002-1799-641X
SPIN-code: 1330-6583
Scopus Author ID: 57194974175

MD, Cand. Sci. (Med.)

Uzbekistan, Samarkand

Alexandr G. Balgley

North-Western State Medical University named after I.I. Mechnikov

Email: balgley.aleksandr@szgmu.ru
ORCID iD: 0000-0003-0964-6871
SPIN-code: 1202-7753
Russian Federation, 41 Kirochnaya St., Saint Petersburg, 191015

Aleksandr N. Tkachenko

North-Western State Medical University named after I.I. Mechnikov

Author for correspondence.
Email: altkachenko@mail.ru

MD, Dr. Sci. (Med.), Professor

Russian Federation, 41 Kirochnaya St., Saint Petersburg, 191015

References

  1. Vina ER, Kwoh CK. Epidemiology of osteoarthritis: literature update. Opin Rheumatol. 2018;30(2):160–167. doi: 10.1097/BOR.0000000000000479
  2. De Frate LE, Kim-Wang SY, Englander ZA, Mc Nulty AL. Osteoarthritis year in review 2018: mechanics. Osteoarthritis Cartilage. 2019;27(3):392–400. doi: 10.1016/j.joca.2018.12.011
  3. Branco JC, Rodrigues AM, Gouveia N, et al. Prevalence of rheumatic and musculoskeletal diseases and their impact on health-related quality of life, physical function and mental health in Portugal: results from EpiReumaPt — a national health survey. RMD Open. 2016;2(1):e000166. doi: 10.1136/rmdopen-2015-000166
  4. Vorokov AA, Bortulev PI, Khaydarov VM, et al. Total hip and knee arthoplasty: on the issue of indications for surgery. Pediatric Traumatology, Orthopaedics, and Reconstructive Surgery. 2020;8(3):355–364. (In Russ.) doi: 10.17816/PTORS34164
  5. Burn E, Murray DW, Hawker GA. Lifetime risk of knee and hip replacement following a GP diagnosis of osteoarthritis: a real-world cohort study. Osteoarthritis Cartilage. 2019;27(11):1627–1635. doi: 10.1016/j.joca.2019.06.004
  6. Bruyère O, Honvo G, Veronese N. An updated algorithm recommendation for the management of knee osteoarthritis from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Semin Arthritis Rheum. 2019;49(3):337–350. doi: 10.1016/j.semarthrit.2019.04.008
  7. Bannuru RR, Osani MC, Vaysbrot EE. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis Cartilage. 2019;27(11):1578–1589. doi: 10.1016/j.joca.2019.06.011
  8. Favero M, Ramonda R, Goldring MB, et al. Early knee osteoarthritis. RMD Open. 2015;1(Suppl 1):e000062. doi: 10.1136/rmdopen-2015-000062
  9. Filardo G, Kon E, Longo UG, et al. Non-surgical treatments for the management of early osteoarthritis. Knee Surg Sports Traumatol Arthrosc. 2016;24(6):1775–1785. doi: 10.1007/s00167-016-4089-y
  10. Lila AM, Alekseeva LI, Taskina EA. Modern approaches to osteoarthritis therapy taking into account updated international recommendations. Russian Medical Inquiry. 2019;3(11–2):48–52. (In Russ.)
  11. Alekseeva LI, Naumov AV. Management of osteoarthritis with comorbidity in general medical practice (clinical recommendations). Doctor.ru. 2017;5(134):51–69. (In Russ.)
  12. Rausch Osthoff AK, Juhl CB, Knittle K, et al. Effects of exercise and physical activity promotion: meta-analysis informing the 2018 EULAR recommendations for physical activity in people with rheumatoid arthritis, spondyloarthritis and hip/knee osteoarthritis. RMD Open. 2018;4(2):e000713. doi: 10.1136/rmdopen-2018-000713
  13. Daste C, Kirren Q, Akoum J, et al. Physical activity for osteoarthritis: Efficiency and review of recommandations. Joint Bone Spine. 2021;88(6):105207. doi: 10.1016/j.jbspin.2021.105207
  14. Abuseva GR, Kovlen DV, Ponomarenko GN, et al. Physical methods of rehabilitation of patients with osteoarthritis: scientometric analysis of evidence-based studies. Traumatology and Orthopedics of Russia. 2020;26(1):190–200. (In Russ.) doi: 10.21823/2311-2905-2020-26-1-190-200
  15. Drapkina OM, Skripnikova IA, Shepel RN, Kaburova AN. Osteoarthritis in the practice of a general practitioner: algorithm of diagnosis and choice of therapy. The Russian Journal of Preventive Medicine. 2018;21(6):12–22. (In Russ.) doi: 10.17116/profmed20182106112
  16. Alekseeva LI, Lila AM. Osteoarthritis background therapy: current view on the glucosamine and chondroitin therapy. Modern Rheumatology Journal. 2021;15(2):112–119. (In Russ.) doi: 10.14412/1996-7012-2021-2-112-119
  17. Majko OYu, Savelova EE. Clinical efficacy of chondroitin sulfate and its combination with glucosamine hydrochloride in the treatment of heart rose and coxarthrosis. Clinical Gerontology. 2016;22(5–6):18–25. (In Russ.)
  18. Henrotin Y, Mobasheri A, Marty M. Is there any scientific evidence for the use of glucosamine in the management of human osteoarthritis? Arthritis Res Ther. 2012;14(1):201. doi: 10.1186/ar3657
  19. Denisov LN, Platova AI, Menshikova IV, Lila AM. Osteoarthritis — aspects of pharmacotherapy. Modern Rheumatology Journal. 2018;12(2):97–102. (In Russ.) doi: 10.14412/1996-7012-2018-2-97-102
  20. Gregori D, Giacovelli G, Minto C, et al. Association of Pharmacological Treatments with long-term pain control in patients with knee osteoarthritis: a systematic review and meta-analysis. JAMA. 2018;320(24):2564–2579. doi: 10.1001/jama.2018.19319
  21. Belyaeva IB, Mazurov VI, Raimuev KV. Current ESCEO recommendations for the treatment of osteoarthritis of the knee joint. Effective pharmacotherapy. 2018;(4):36–41. (In Russ.)
  22. Kraus VB, Blanco FJ, Englund M, et al. Call for standardized definitions of osteoarthritis and risk stratification for clinical trials and clinical use. Osteoarthritis Cartilage. 2015;23(8):1233–1241. doi: 10.1016/j.joca.2015.03.036
  23. Krylova IN, Tikhonov DA. Chondroprotectors (mechanism of action, efficiency and safety). Experimental and Clinical Pharmacology. 2018;81(7):39–44. (In Russ.) doi: 10.30906/0869-2092-2018-81-7-39-44
  24. Yang W, Sun C, He SQ, et al. The efficacy and safety of disease-modifying osteoarthritis drugs for knee and hip osteoarthritis — a systematic review and network meta-analysis. J Gen Intern Med. 2021;36(7):2085–2093. doi: 10.1007/s11606-021-06755-z
  25. Uryasyev OM, Zaigrova NK. Osteoarthritis: pathogenesis, diagnosis, treatment. Zemsky doctor. 2016;(1–2(29–30)):27–35. (In Russ.)
  26. Bhala N, Emberson J, Merhi A, et al. Coxib and traditional NSAID Trialists’ (CNT) Collaboration. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet. 2013;382(9894):769–779. doi: 10.1016/S0140-6736(13)60900-9
  27. Voronko IA. The place of hyaluronic acid preparations in the treatment of osteoarthritis. Medical news. 2018;2(281):24–28. (In Russ.)
  28. Jüni P, Hari R, Rutjes AW, et al. Intra-articular corticosteroid for knee osteoarthritis. Cochrane Database Syst Rev. 2015;2015(10):CD005328. doi: 10.1002/14651858.cd005328.pub3
  29. Gazendam A, Ekhtiari S, Bozzo A, et al. Intra-articular saline injection is as effective as corticosteroids, platelet-rich plasma and hyaluronic acid for hip osteoarthritis pain: a systematic review and network meta-analysis of randomised controlled trials. Br J Sports Med. 2021;55(5):256–261. doi: 10.1136/bjsports-2020-102179
  30. Kandel L, Agar G, Elkayam O, et al. A novel approach for knee osteoarthritis using high molecular weight hyaluronic acid conjugated to plasma fibrinogen — interim findings of a double-blind clinical study. Heliyon. 2020;6(7):e04475. doi: 10.1016/j.heliyon.2020.e04475
  31. Xie X, Zhang C, Tuan RS. Biology of platelet-rich plasma and its clinical application in cartilage repair. Arthritis Res Ther. 2014;16(1):204. doi: 10.1186/ar4493
  32. Shen L, Yuan T, Chen S, et al. The temporal effect of platelet-rich plasma on pain and physical function in the treatment of knee osteoarthritis: systematic review and meta-analysis of randomized controlled trials. J Orthop Surg Res. 2017;12(1):16. doi: 10.1186/s13018-017-0521-3
  33. Citrome L, Weiss–Citrome AA. Systematic review of duloxetine for osteoarthritic pain: What is the number needed to treat, number needed to harm, and likelihood to be helped or harmed? Postgrad Med. 2012;124(1):83–93. doi: 10.3810/pgm.2012.01.2521
  34. Kawarai Y, Orita S, Nakamura J, et al. Analgesic effect of duloxetine on an animal model of monosodium iodoacetate-induced hip osteoarthritis. J Orthop Res. 2020;38(2):422–430. doi: 10.1002/jor.24480
  35. Blikman T, Rienstra W, van Raaij TM. Duloxetine in OsteoArthritis (DOA) study: effects of duloxetine on pain and function in end-stage hip and knee OA — a pragmatic enriched randomized controlled trial. BMC Musculoskelet Disord. 2022;23(1):115. doi: 10.1186/s12891-022-05034-0
  36. Zborovskaya IA, Mozgovaya EE, Bedina SA, et al. Osteoarthritis — a modern view of treatment. Lekarstvennyj vestnik. 2019;13(4(76)):7–15. (In Russ.)
  37. Sarana AM, Krassiy AB, Golota AS, et al. Cellular technologies in the treatment of osteoarthritis of the hip joint: a review of registered clinical trials. Medical Alliance. 2021;(2):29–33. (In Russ.)
  38. Riddle DL, Jiranek WA, Hayes CW. Use of a validated algorithm to judge the appropriateness of total knee arthroplasty in the United States: a multicenter longitudinal cohort study. Arthritis Rheumatol. 2014;66(8):2134–2143. doi: 10.1002/art.38685
  39. Nazarov EA, Zubov AA, Ryabova MN, et al. Safe operations in the treatment of degenerative-dystrophic joint diseases or how to avoid arthroplasty? Proceedings of the conference “Achievements of Russian traumatology and orthopedics”. Saint Petersburg; 2018. P. 238–240. (In Russ.)
  40. Solomin LN. Osnovy chreskostnogo osteosinteza. Moscow: BINOM; 2015. Vol. 2. P. 590–645. (In Russ.)
  41. Paley D, Kocaoğlu M, Bilen FE. Combined technique: Correction of long bone deformities using fixator-assisted nailing. Springer: Berlin Heidelberg; 2015. P. 33–47. doi: 10.1007/978-3-642-55026-3_2
  42. Yadav AK, Parihar M, Pawar ED, et al. Functional outcome of high tibial osteotomy in patients with medial compartment osteoarthritis using dynamic axial fixator — a prospective study. J Clin Orthop Trauma. 2020;11(Suppl 5):S902–S908. doi: 10.1016/j.jcot.2020.07.033
  43. Ross JR, Larson CM, Bedi A. Indications for hip arthroscopy. Sports Health. 2017;9(5):402–413. doi: 10.1177/1941738117712675
  44. Yakupova ER. Possibilities of hip arthroscopy. In: Novoe slovo v nauke. Penza: Nauka i Prosveshchenie, 2020. Chapter 9. P. 109–119. (In Russ.)
  45. Jamil M, Dandachli W, Noordin S, Witt J. Hip arthroscopy: Indications, outcomes and complications. Int J Surg. 2018;54(Pt B):341–344. doi: 10.1016/j.ijsu.2017.08.557
  46. Volokitina EA, Kutepov SM, Gilev MV, et al. Kompleksnoe lechenie osteoartrita krupnykh sustavov: uchebno-metodicheskoe posobie. Ekaterinburg; 2020. (In Russ.)
  47. Gerasimov SA, Zykin AA, Korytkin AA, et al. Arthroscopic management of femoroacetabular impingement: evaluation of a two-year follow-up. Orthopaedic Genius. 2020;26(3):353–358. (In Russ.) doi: 10.18019/1028-4427-2020-26-3-353-358
  48. Morattel B, Bonin N. Unusual apical femoral head deformity treated by hip arthroscopy and tunnel drilling through femoral head: a case report. J Hip Preserv Surg. 2021;8(Suppl 1):i25–i33. doi: 10.1093/jhps/hnab026
  49. Bedard NA, Pugely AJ, Duchman KR, et al. When hip scopes fail, they do so quickly. J Arthroplasty. 2016;31(6):1183–1187. doi: 10.1016/j.arth.2015.12.024
  50. Drobniewski M, Synder M, Skrzypek M, et al. Hip joint arthroscopy in professionally active patients with osteoarthritis. Int J Occup Med Environ Health. 2019;32(1):115–120. doi: 10.13075/ijomeh.1896.01381
  51. Mardones R, Larrain C. Cartilage restoration technique of the hip. J Hip Preserv Surg. 2015;3(1):30–36. doi: 10.1093/jhps/hnv061
  52. .Gilfanov SI, Semenov AI, Netsvetaev KE, Stepanova AI. Indications for arthroscopy of the central and peripheral parts of the hip joint. Kremlin Medical Journal. 2017;(4–2):96–102. (In Russ.)
  53. Olyunin YuA. Osteoarthritis: modern principles of treatment and prerequisites for the development of personalized therapy. Modern Rheumatology Journal. 2016;10(3):81–86. (In Russ.) doi: 10.14412/1996-7012-2016-3-81-86
  54. Zarringam D, Saris DBF, Bekkers JEJ. Identification of early prognostic factors for knee and hip arthroplasty; a long-term follow-up of the CHECK cohort. J Orthop. 2019;19:41–45. doi: 10.1016/j.jor.2019.10.020
  55. Vina ER, Ran D, Ashbeck EL, et al. Patient preferences for total knee replacement surgery: Relationship to clinical outcomes and stability of patient preferences over 2 years. Semin Arthritis Rheum. 2016;46(1):27–33. doi: 10.1016/j.semarthrit.2016.03.012
  56. de Jesus C, Stacey D, Dervin GF Evaluation of a patient decision aid for unicompartmental or total knee arthroplasty for medial knee osteoarthritis. J Arthroplasty. 2017;32(11):3340–3344. doi: 10.1016/j.arth.2017.06.014
  57. Cronström A, Dahlberg LE, Nero H, Hammarlund CS. “I was considering surgery because I believed that was how it was treated”: a qualitative study on willingness for joint surgery after completion of a digital management program for osteoarthritis. Osteoarthritis Cartilage. 2019;27(7):1026–1032. doi: 10.1016/j.joca.2019.04.004
  58. Shukurova SM, Khamraeva ZD, Shodiev BR, Karimova GN. Osteoarthritis as an important problem of geriatrics. Avicenna Bulletin. 2016;1(66):137–143. (In Russ.)
  59. Austin DC, Torchia MT, Moschetti WE, et al. Patient outcomes after total hip arthroplasty in extreme elderly patients older than 80 years. Hip Int. 2020;30(4):407–416. doi: 10.1177/1120700019837943
  60. Kunkel ST, Sabatino MJ, Kang R, et al. The cost-effectiveness of total hip arthroplasty in patients 80 years of age and older. J Arthroplasty. 2018;33(5):1359–1367. doi: 10.1016/j.arth.2017.11.063
  61. Clinical recommendations — Coxarthrosis — 2021–2022–2023 [Internet]. Available from: http://disuria.ru/_ld/10/1086_kr21M16MZ.pdf. Accessed: June 28, 2022. (In Russ.)

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2023 Eco-Vector



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 71733 от 08.12.2017.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies